Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia

Eur Neuropsychopharmacol. 2007 Sep;17(9):567-72. doi: 10.1016/j.euroneuro.2006.12.003. Epub 2007 Jan 23.

Abstract

We review the role of two susceptibility genes; G72 and DAAO in glutamate neurotransmission and the aetiology of schizophrenia. The gene product of G72 is an activator of DAAO (D-amino acid oxidase), which is the only enzyme oxidising D-serine. D-serine is an important co-agonist for the NMDA glutamate receptor and plays a role in neuronal migration and cell death. Studies of D-serine revealed lower serum levels in schizophrenia patients as compared to healthy controls. Furthermore, administration of D-serine as add-on medication reduced the symptoms of schizophrenia. The underlying mechanism of the involvement of G72 and DAAO in schizophrenia is probably based on decreased levels of D-serine and decreased NMDA receptor functioning in patients. The involvement of this gene is therefore indirect support for the glutamate dysfunction hypothesis in schizophrenia.

Publication types

  • Review

MeSH terms

  • Carrier Proteins / genetics
  • Carrier Proteins / physiology*
  • D-Amino-Acid Oxidase / genetics
  • D-Amino-Acid Oxidase / physiology*
  • Genetic Predisposition to Disease
  • Glutamic Acid / metabolism*
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Models, Biological
  • Schizophrenia / genetics
  • Schizophrenia / metabolism*
  • Schizophrenia / physiopathology
  • Synaptic Transmission / genetics*

Substances

  • Carrier Proteins
  • DAOA protein, human
  • Intracellular Signaling Peptides and Proteins
  • Glutamic Acid
  • D-Amino-Acid Oxidase